Chinese Journal of Stomatological Continuing Education ›› 2025, Vol. 28 ›› Issue (5): 312-321.DOI: 10.12337/zgkqjxjyzz.2025.05.003
Previous Articles Next Articles
Bingyue Xu, Han Lu, Keying Liu, Wei He*
Online:2025-09-30
Published:2025-09-30
Contact:
Wei He. Tel: 0371-66862263. Email: Bingyue Xu, Han Lu, Keying Liu, Wei He. Advances in the Study of Microecological Dysbiosis in Medication-Related Osteonecrosis of the Jaw[J]. Chinese Journal of Stomatological Continuing Education, 2025, 28(5): 312-321.
Add to citation manager EndNote|Ris|BibTeX
URL: https://jxjyzz.cndent.com/EN/10.12337/zgkqjxjyzz.2025.05.003
| [1] Fusco V, Campisi G, Bedogni A.One changing and challenging scenario: The treatment of cancer patients with bone metastases by bisphosphonates and denosumab, the cost-benefit evaluation of different options, and the risk of medication-related osteonecrosis of the jaw (MRONJ)[J]. Support Care Cancer, 2022, 30(9):7047-7051. [2] Haviv Y, Geller Z, Mazor S, et al.Pain characteristics in medication-related osteonecrosis of the jaws[J]. Support Care Cancer, 2021, 29(2):1073-1080. [3] Lee K, Kim K, Kim JY, et al.Mechanisms underlying medication-related osteonecrosis of the jaw[J]. Oral Dis, 2025, 31(4):1073-1083. [4] Otsuru M, Fujiki Y, Soutome S, et al.Risk factors for dental findings of the development of MRONJ: Investigation of 3734 teeth in cancer patients receiving high-dose antiresorptive agents[J]. J Dent Sci, 2024, 19(1):203-210. [5] Li Q, Pu Y, Lu H, et al.Porphyromonas, Treponema, and Mogibacterium promote IL8/IFNγ/TNFα-based pro-inflammation in patients with medication-related osteonecrosis of the jaw[J]. J Oral Microbiol, 2020, 13(1):1851112. [6] Russmueller G, Seemann R, Weiss K, et al.The association of medication-related osteonecrosis of the jaw with Actinomyces spp. infection[J]. Sci Rep, 2016, 6:31604. [7] Du W, Yang M, Kim T, et al.Indigenous microbiota protects development of medication-related osteonecrosis induced by periapical disease in mice[J]. Int J Oral Sci, 2022, 14(1):16. [8] Williams DW, Vuong HE, Kim S, et al.Indigenous microbiota protects against inflammation-induced osteonecrosis[J]. J Dent Res, 2020, 99(6):676-684. [9] Ibrahim N, Apandi NIM, Shuhardi SA, et al.Actinomyces sp. presence in the bone specimens of patients with osteonecrosis of the jaw: The histopathological analysis and clinical implication[J]. Antibiotics (Basel), 2022, 11(8):1067. [10] Zirk M, Wenzel C, Buller J, et al.Microbial diversity in infections of patients with medication-related osteonecrosis of the jaw[J]. Clin Oral Investig, 2019, 23(5):2143-2151. [11] Zhang W, Gao L, Ren W, et al.The role of the immune response in the development of medication-related osteonecrosis of the jaw[J]. Front Immunol, 2021, 12:606043. [12] Katsarelis H, Shah NP, Dhariwal DK, et al.Infection and medication-related osteonecrosis of the jaw[J]. J Dent Res, 2015, 94(4):534-539. [13] Choi NR, Na HS, Han H, et al.Next-generation sequencing analysis of bacterial species present in the sequestrum of medication-related osteonecrosis of the jaw patients[J]. Arch Oral Biol, 2025;172:106180. [14] Hallmer F, Bjørnland T, Andersson G, et al.Bacterial diversity in medication-related osteonecrosis of the jaw[J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2017, 123(4):436-444. [15] Kövér Z, Bán Á, Gajdács M, et al.Role of Actinomyces spp. and related organisms in the development of MRONJ: Clinical evidence based on a case series[J]. Eur J Microbiol Immunol (Bp), 2023, 13(4):125-134. [16] Panya S, Fliefel R, Probst F, et al.Role of microbiological culture and polymerase chain reaction (PCR) of actinomyces in medication-related osteonecrosis of the jaw (MRONJ)[J]. J Craniomaxillofac Surg, 2017, 45(3):357-363. [17] Kim HY, Jung YS, Park W, et al.Can medication-related osteonecrosis of the jaw be attributed to specific microorganisms through oral microbiota analyses? A preliminary study[J]. BMC Oral Health, 2024, 24(1):160. [18] Bassan Marinho Maciel G, Marinho Maciel R, Linhares Ferrazzo K, et al. Etiopathogenesis of medication-related osteonecrosis of the jaws: A review[J]. J Mol Med (Berl), 2024, 102(3):353-364. [19] Boff RC, Salum FG, Figueiredo MA, et al.Important aspects regarding the role of microorganisms in bisphosphonate-related osteonecrosis of the jaws[J]. Arch Oral Biol, 2014, 59(8):790-799. [20] Scheller EL, Baldwin CM, Kuo S, et al.Bisphosphonates inhibit expression of p63 by oral keratinocytes[J]. J Dent Res, 2011, 90(7): 894-899. [21] Vozna IV, Pavlov SV, Voznyi OV.The influence of oral antimicrobial peptide content on the quantitative microflora composition in periodontal pockets among residents of a large industrial region[J]. Zaporozhye Medical Journal, 2021, 23(3):388-394. [22] Jelin-Uhlig S, Weigel M, Ott B, et al.Bisphosphonate-related osteonecrosis of the jaw and oral microbiome: Clinical risk factors, pathophysiology and treatment options[J]. Int J Mol Sci, 2024, 25(15):8053. [23] Gawęda A, Kałuża A, Wojciechowicz J, et al.Necrosis BRONJ of the mandible, complicated by Actinomyces infection: Case report[J]. J Pre Clin Clin Res, 2018, 12(3):82-86. [24] Aguirre JI, Castillo EJ, Kimmel DB.Biologic and pathologic aspects of osteocytes in the setting of medication-related osteonecrosis of the jaw (MRONJ)[J]. Bone, 2021, 153:116168. [25] Yahara H, Hiraki A, Maruoka Y, et al.Shotgun metagenome sequencing identification of a set of genes encoded by Actinomyces associated with medication-related osteonecrosis of the jaw[J]. PLoS One, 2020, 15(11):e0241676. [26] Wu S, Li F, Tan J, et al.Porphyromonas gingivalis induces bisphosphonate-related osteonecrosis of the femur in mice[J]. Front Cell Infect Microbiol, 2022, 12:886411. [27] Zhu B, Macleod LC, Newsome E, et al.Aggregatibacter actinomycetemcomitans mediates protection of Porphyromonas gingivalis from Streptococcus sanguinis hydrogen peroxide production in multi-species biofilms[J]. Sci Rep, 2019, 9(1):4944. [28] Könönen E.Polymicrobial infections with Actinomyces and related organisms: Taxonomy and clinical significance[J]. J Oral Microbiol, 2024, 16(1):2354148. [29] Yamaguchi-Kuroda Y, Kikuchi Y, Kokubu E, et al.Porphyromonas gingivalis diffusible signaling molecules enhance Fusobacterium nucleatum biofilm formation via gene expression modulation[J]. J Oral Microbiol, 2023, 15(1):2165001. [30] Sedghizadeh PP, Kumar SK, Gorur A, et al.Identification of microbial biofilms in osteonecrosis of the jaws secondary to bisphosphonate therapy[J]. J Oral Maxillofac Surg, 2008, 66(4):767-775. [31] Wang J, Liu C, Cutler J, et al.Microbial- and host immune cell-derived extracellular vesicles in the pathogenesis and therapy of periodontitis: A narrative review[J]. J Periodontal Res, 2024, 59(6):1115-1129. [32] Peyyala R, Kirakodu SS, Novak KF, et al.Oral epithelial cell responses to multispecies microbial biofilms[J]. J Dent Res, 2013, 92(3):235-240. [33] Anselmi NK, Vanyo ST, Clark ND, et al.Topology and functional characterization of major outer membrane proteins of Treponema maltophilum and Treponema lecithinolyticum[J]. Mol Oral Microbiol, 2025, 40(1):17-36. [34] Liu G, Cheng C, Guan X, et al.α-Hemolysin suppresses osteogenesis by inducing lipid rafts accumulation in bone marrow stromal cells[J]. Food Chem Toxicol, 2020, 145:111689. [35] Sullivan DC, Chapman SW.Bacteria that masquerade as fungi: Actinomycosis/nocardia[J]. Proc Am Thorac Soc, 2010, 7(3):216-221. [36] Horiuchi A, Kokubu E, Warita T, et al.Synergistic biofilm formation by Parvimonas micra and Fusobacterium nucleatum[J]. Anaerobe, 2020, 62:102100. [37] Escalante-Herrera A, Chaves M, Villamil JC, et al.In vitro assessment of the antimicrobial activity of tetracycline hydrochloride diluted in three different vehicles against Porphyromonas gingivalis, Prevotella intermedia, and Fusobacterium nucleatum[J]. J Indian Soc Periodontol, 2022, 26(2):104-109. [38] Kövér Z, Gajdács M, Polgár B, et al.The microbiological background of medication-related osteonecrosis of the jaw (MRONJ): Clinical evidence based on traditional culture and molecular biological detection methods[J]. Antibiotics (Basel), 2025, 14(2):203. [39] 代静, 陈燕斌, 陈珊, 等. 牙科修复材料苯扎氯铵表面活性剂对5种常见口腔致病菌的体外抑菌效果[J]. 中国组织工程研究, 2018, 22(18):2849-2854. [40] He L, Wang W, Ma L, et al.Emergence of a clinical Klebsiella pneumoniae harboring an acrAB-tolC in chromosome and carrying the two repetitive tandem core structures for blaKPC-2 and blaCTX-M-65 in a plasmid[J]. Front Cell Infect Microbiol, 2024, 14:1410921. [41] Badros AZ, Meddeb M, Weikel D, et al.Prospective observational study of bisphosphonate-related osteonecrosis of the jaw in multiple myeloma: Microbiota profiling and cytokine expression[J]. Front Oncol, 2021, 11:704722. [42] Pushalkar S, Li X, Kurago Z, et al.Oral microbiota and host innate immune response in bisphosphonate-related osteonecrosis of the jaw[J]. Int J Oral Sci, 2014, 6(4):219-226. [43] Wolff A, Rodloff AC, Vielkind P, et al.Antimicrobial susceptibility of clinical oral isolates of Actinomyces spp[J]. Microorganisms, 2022, 10(1):125. [44] Zirk M, Kreppel M, Buller J, et al.The impact of surgical intervention and antibiotics on MRONJ stage II and III: A retrospective study[J]. J Craniomaxillofac Surg, 2017, 45(8):1183-1189. [45] 王铝亚, 张竞心, 林洁. 口腔术后聚维酮碘与氯己定控制感染效果的系统评价分析[J]. 国际口腔医学杂志, 2023, 50(4):438-444. [46] Ewald F, Wuesthoff F, Koehnke R, et al.Retrospective analysis of bacterial colonization of necrotic bone and antibiotic resistance in 98 patients with medication-related osteonecrosis of the jaw (MRONJ)[J]. Clin Oral Investig, 2021, 25(5):2801-2809. [47] Kuehn S, Scariot R, Elsalanty M.Medication-related osteonecrosis: Why the jawbone?[J]. Dent J (Basel), 2023, 11(5):109. [48] Crincoli V, Ballini A, Di Comite M, et al.Microbiological investigation of medication-related osteonecrosis of the jaw: Preliminary results[J]. J Biol Regul Homeost Agents, 2015, 29(4):977-983. [49] Yamagata K, Uchida F, Kanno N, et al.Chapter: Medication-related osteonecrosis of the jaw. Osteonecrosis[M]. Berlin: Springer, 2017. [50] Hoefert S.Chapter: Microbiology and antibiotics in the context of medication-related osteonecrosis of the jaw. Medication-Related Osteonecrosis of the Jaws[M]. Berlin: Springer, 2015:121-129. [51] Brody A, Scheich B, Dobo-Nagy C.Targeted histological evaluation shows high incidence of Actinomyces infection in medication-related osteonecrosis of the jaws[J]. Sci Rep, 2022, 12(1):3406. [52] Qin M, Zhang X, Ding H, et al.Engineered Probiotic Bio-Heterojunction with Robust Antibiofilm Modality via “Eating” Extracellular Polymeric Substances for Wound Regeneration[J]. Adv Mater, 2024, 36(35):e2402530. [53] 蔡晨晨, 刘济远, 唐休发, 等. 药物相关性颌骨坏死治疗的研究进展[J]. 中国医学前沿杂志(电子版), 2023, 15(5):37-45. [54] Goker F, Grecchi E, Grecchi F, et al.Treatment of medication-related osteonecrosis of the jaw (MRONJ): A systematic review[J]. Eur Rev Med Pharmacol Sci, 2021, 25(6):2662-2673. [55] Heifetz-Li JJ, Abdelsamie S, Campbell CB, et al. Systematic review of the use of pentoxifylline and tocopherol for the treatment of medication-related osteonecrosis of the jaw[J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2019, 128(5):491-497.e2. [56] Hanna R, Miron IC, Dalvi S, et al.A systematic review of laser photobiomodulation dosimetry and treatment protocols in the management of medications-related osteonecrosis of the jaws: a rationalised consensus for future randomised controlled clinical trials[J]. Pharmaceuticals (Basel), 2024, 17(8):1011. [57] Bennardo F, Barone S, Antonelli A, et al.Autologous platelet concentrates as adjuvant in the surgical management of medication-related osteonecrosis of the jaw[J]. Periodontol 2000, 2025, 97(1):287-307. [58] Kobayashi E, Takahashi H, Igarashi K, et al.Prognosis of medication-related osteonecrosis of the jaw with surgical treatment[J]. J Hard Tissue Biol, 2022, 31(1):39-46. [59] Ruggiero SL, Kohn N.Disease stage and mode of therapy are important determinants of treatment outcomes for medication-related osteonecrosis of the jaw[J]. J Oral Maxillofac Surg, 2015, 73(12 Suppl):S94-S100. [60] Fusco V, Fasciolo A, Gambino A, et al.1794P-Inadequacy of current definition and staging system of medication-related osteonecrosis of jaw (MRONJ) released by AAOMS: A computed tomography study in 151 cancer and myeloma patients[J]. Ann Oncol, 2019, 30(Suppl 5):v731. [61] 郭玉兴, 张建运, 王佃灿, 等. 药物相关颌骨骨坏死的病理特点及临床治疗策略[J]. 北京大学学报(医学版), 2022, 54(6):1190-1195. |
| [1] | Yihui Ding, Dandan Wang, Chenlu Li, Jihong Wang, Lei Tian, Chunlin Zong. Effect of Teriparatide on Therapy of Medication-related Osteonecrosis of the Jaw [J]. Chinese Journal of Stomatological Continuing Education, 2025, 28(5): 297-306. |
| [2] | Jinyuan He, Guowen Sun. Research Progress on the Mechanism and Treatment of Medication-related Osteonecrosis of the Jaw [J]. Chinese Journal of Stomatological Continuing Education, 2025, 28(5): 307-311. |
| [3] | Yiyun Zhang, Feiwu Kang, Xueming Zhang. Research Advances in Non-Surgical Management of Medication-Related Osteonecrosis of the Jaw [J]. Chinese Journal of Stomatological Continuing Education, 2025, 28(5): 322-330. |
| [4] | Chenxi Jiang, Guowen Sun. Research Progress in Clinical Diagnosis and Treatment of Medication-Related Osteonecrosis of the Jaw [J]. Chinese Journal of Stomatological Continuing Education, 2025, 28(5): 331-336. |
| [5] | Rui Wang, Guowen Sun. A Retrospective Study of Surgical Treatment of Stage 3 Medication-Related Osteonecrosis of the Jaw [J]. Chinese Journal of Stomatological Continuing Education, 2025, 28(5): 345-352. |
| [6] | Jinyuan He, Guowen Sun. One Case of the Guide Plate to Improve the Occlusal Relationship of Mandibular Medication-related Osteonecrosis of the Jaw [J]. Chinese Journal of Stomatological Continuing Education, 2025, 28(5): 360-366. |
| [7] | Na Li, Yuan Chang, Ning Gao, Kun Fu, Jinghua Cai, Zhenjie GAO, Xianghe Qiao, Leilei Yang, Wei He. Clinical Application of “Internet+”Case Teaching Method in Medication-related Osteonecrosis of the Jaw [J]. Chinese Journal of Stomatological Continuing Education, 2025, 28(5): 367-374. |
| [8] | Qianqian Xie, Xiuqiu Gao. Periodontal-orthodontic Treatment for Patients with Generelized Stage IV Grade C Periodontitis: A Case Report [J]. Chinese Journal of Stomatological Continuing Education, 2025, 28(4): 284-295. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||